Vaccination with messenger RNA (mRNA)

Handbook of Experimental Pharmacology

Volumn 183, Issue , 2008, Pages 221-235

  Pascolo, Steve ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; MESSENGER RNA; RECOMBINANT VACCINE;

ANIMAL; CHEMISTRY; CLINICAL TRIAL; DENDRITIC CELL; DRUG DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; IMMUNOLOGY; MONOCYTE; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CLINICAL TRIALS AS TOPIC; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; HUMANS; MONOCYTES; RNA, MESSENGER; TRANSFECTION; VACCINES, SYNTHETIC;

EID: 39349103969     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-72167-3_11     Document Type: Article

References (38)

1. Anonymous (2003) Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: Phase II study results. Ophthalmol 110: 979-986
2. Anthony LS, Wu H, Sweet H, Turnnir C, Boux LJ, Mizzen LA (1999) Priming of CD8+ CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule. Vaccine 17: 373-383
3. Boczkowski D, Nair SK, Snyder D, Gilboa E (1996) Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp. Med. 184: 465-472
4. Boyle JS, Koniaras C, Lew AM (1997) Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: Cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol 9: 1897-1906
5. Carralot JP, Probst J, Hoerr I, Scheel B, Teufel R, Jung G, Rammensee HG, Pascolo S (2004) Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cell Mol Life Sci 61: 2418-2424
6. Chhabra A, Mehrotra S, Chakraborty NG, Mukherji B, Dorsky DI (2004) Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation. Eur J Immunol 34: 2824-2833
7. Conry RM, LoBuglio AF, Wright M, Sumerel L, Pike MJ, Johanning F, Benjamin R, Lu D, Curiel DT (1995) Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 55: 1397-1400
8. Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, Yancey D, Zhang A, Dahm P, Chao N, Gilboa E, Vieweg J (2005) Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 115: 3623-3633
9. Grover A, Kim GJ, Lizee G, Tschoi M, Wang G, Wunderlich JR, Rosenberg SA, Hwang ST, Hwu P (2006) Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes. Clin Cancer Res 12: 5801-5808
10. Heiser A, Coleman D, Dannull J, Yancey D, Maurice MA, Lallas CD, Dahm P, Niedzwiecki D, Gilboa E, Vieweg J (2002) Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest 109: 409-417
11. Hess PR, Boczkowski D, Nair SK, Snyder D, Gilboa E (2006) Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen. Cancer Immunol Immunother 55: 672-683
12. Hoerr I, Obst R, Rammensee HG, Jung G (2000) In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol 30: 1-7
13. Holcik M, Liebhaber SA (1997) Four highly stable eukaryotic mRNAs assemble 3- untranslated region RNA-protein complexes sharing cis and trans components. Proc Natl Acad Sci USA 94: 2410-2414
14. Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, Tureci O, Sahin U (2006) Modification of antigen-encoding RNA increases stability, translational efficacy, and T cell stimulatory capacity of dendritic cells. Blood 108: 4009-4017
15. S. Pascolo Hung CF, Hsu KF, Cheng WF, Chai CY, He L, Ling M, Wu TC (2001) Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Cancer Res 61: 1080-1088
16. Klencke B, Matijevic M, Urban RG, Lathey JL, Hedley ML, Berry M, Thatcher J, Weinberg V, Wilson J, Darragh T, Jay N, Da Costa M, Palefsky JM (2002) Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: A Phase I study of ZYC101. Clin Cancer Res 8: 1028-1037
17. Kozak M (1978) How do eukaryotic ribosomes select initiation regions in messenger RNA? Cell 15: 1109-1123
18. Kyte JA, Gaudernack G (2006) Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells. Cancer Immunol Immunother 55: 1432-1442
19. Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M, Gullestad HP, Ryder T, Lislerud K, Hammerstad H, Gaudernack G (2006) Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA Cancer Gene Ther 13: 905-918
20. Malone RW, Felgner PL, Verma IM (1989) Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 86: 6077-6081
21. Martin-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F (2003) Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J Exp Med 198: 615-621
22. Martinon F, Krishnan S, Lenzen G, Magne R, Gomard E, Guillet JG, Levy JP, Meulien P (1993) Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol 23: 1719-1722
23. Mockey M, Goncalves C, Dupuy FP, Lemoine FM, Pichon C, Midoux P (2006) mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level. Biochem Biophys Res Commun 340: 1062-1068
24. Momburg F, Fuchs S, Drexler J, Busch R, Post M, Hammerling GJ, Adorini L (1993) Epitopespecific enhancement of antigen presentation by invariant chain. J Exp Med. 178: 1453-1458
25. Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, Hammerstad H,Waehre H, Raabe N, Gaudernack G (2005) Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer 93: 749-756
26. Nishikawa M, HashidaM(2002) Nonviral approaches satisfying various requirements for effective in vivo gene therapy. Biol Pharm Bull 25: 275-283
27. Probst J, Brechtel S, Scheel B, Hoerr I, Jung G, Rammensee HG, Pascolo S (2006) Characterization of the ribonuclease activity on the skin surface. Genet Vaccines Ther 4: 4
28. Probst J, Weide B, Scheel B, Pichler BJ, Hoerr I, Rammensee HG, Pascolo S (2007) Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent. Gene Ther. 2007 Aug; 14(15):1175-80. Epub 2007 May 3
29. Qiu P, Ziegelhoffer P, Sun J, Yang NS (1996) Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther 3: 262-268
30. Ross J (1995) mRNA stability in mammalian cells. Microbiol Rev 59: 423-450
31. Ruff AL, Guarnieri FG, Staveley-OCarroll K, Siliciano RF, August JT (1997) The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. J Biol Chem 272: 8671-8678
32. Steitz J, Britten CM, Wolfel T, Tuting T (2006) Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFPTRP2. Cancer Immunol Immunother 55: 246-253
33. Stepinski J,Waddell C, Stolarski R, Darzynkiewicz E, Rhoads RE (2001) Synthesis and properties of mRNAs containing the novel "anti-reverse" Cap analogs 7-methyl(3-O-methyl)GpppG and 7-methyl (3-deoxy)GpppG RNA 7: 1486-1495
34. Su Z, Dannull J, Heiser A, Yancey D, Pruitt S, Madden J, Coleman D, Niedzwiecki D, Gilboa E, Vieweg J (2003) Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res 63: 2127-2133
35. Thurner B, Roder C, Dieckmann D, Heuer M, Kruse M, Glaser A, Keikavoussi P, Kampgen E, Bender A, Schuler G (1999) Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Meth 223: 1-15
36. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A and (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745-1749
37. Wolff JA, Budker V (2005) The mechanism of naked DNA uptake and expression. Adv Genet 54: 3-20
38. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468